Skip to main content
OpenTrials

Clinical trial condition

Prurigo Nodularis

Explore clinical trials studying Prurigo Nodularis. Study availability and eligibility vary by location and protocol.

35 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Prurigo Nodularis trial results

Completed

A Study of CDX-0159 in Patients With Prurigo Nodularis

NCT04944862

Conditions
Prurigo Nodularis
Locations
  • Desert Sky Dermatology Tempe, Arizona, United States
  • University of Miami, Dermatology Clinical Trials Unit Miami, Florida, United States
  • Revival Research Institute, LLC Troy, Michigan, United States
  • University of New Mexico Albuquerque, New Mexico, United States
View all 17 locations
View Trial Details
Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

NCT03546816

Conditions
Pathological Conditions, Signs and Symptoms, Prurigo Nodularis, Pruritus, +4 more
Locations
  • Study Site 504 Birmingham, Alabama, United States
  • Study Site 533 Rogers, Arkansas, United States
  • Study Site 204 Fremont, California, United States
  • Study Site 383 North Hollywood, California, United States
View all 49 locations
View Trial Details
Completed

A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

NCT02196324

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +11 more
Locations
  • Study Site 08 Bonn, Germany
  • Study Site 06 Dresden, Germany
  • Study Site 12 Düsseldorf, Germany
  • Study Site 02 Frankfurt, Germany
View all 15 locations
View Trial Details
Completed

Safety and Efficacy of Nemolizumab in PN

NCT03181503

Conditions
Prurigo Nodularis
Locations
  • LKH-Univ. Klinikum Graz Graz, Austria
  • Centre-Hospitalier Universitaire (CHU) - Hopital Morvan - Br Brest, France
  • CHU de Nice - Hôpital Archet 2 Nice, France
  • Hopital Saint-Louis - Dermatology Paris, France
View all 16 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

NCT06516952

Conditions
Prurigo Nodularis
Locations
  • Cahaba Dermatology Birmingham, Alabama, United States
  • Banner - University Medicine Multispecialty Services Clinic Tucson, Arizona, United States
  • Premier Dermatology Clinical Trials Institute At Northwest Arkansas Fayetteville, Arkansas, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
View all 120 locations
View Trial Details

Related conditions